In an interview on CNBC’s Mad Money, Charles River CEO Jim Foster said: “We’re helping get drugs to the market faster at a lesser cost… The biotech/pharma relationship is beneficial to the industry and customers… Our business has been growing at double digits in China… We enjoy doing business in China and the government has been reasonable in terms of our expansion plans.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.